A 28-week gestation male infant is delivered via emergency cesarean section for placental abruption. Birth weight 1.2 kg. At 2 hours of life, the infant develops grunting, nasal flaring, and intercostal retractions. Oxygen saturation drops to 88% on room air. Chest X-ray shows a fine reticular granular pattern with air bronchograms and a ground-glass appearance. What is the most likely diagnosis?

Explanation

## Clinical Presentation & Diagnosis **Key Point:** Respiratory Distress Syndrome (RDS), also called Hyaline Membrane Disease (HMD), is the most common cause of respiratory distress in preterm infants and is caused by surfactant deficiency. ### Why This Case Fits RDS 1. **Gestational age:** 28 weeks is in the highest-risk window (22–32 weeks). Surfactant production begins at ~24 weeks but is insufficient until 34–36 weeks. 2. **Timing of onset:** Symptoms within the first 2 hours of life are classic for RDS; other conditions (TTN, meconium aspiration) typically present later or have different triggers. 3. **Clinical signs:** Grunting (attempt to maintain positive end-expiratory pressure), nasal flaring, intercostal retractions, and hypoxemia are hallmark features. 4. **Chest X-ray findings:** The fine reticular granular pattern with air bronchograms and ground-glass appearance is pathognomonic for HMD. This represents atelectasis alternating with hyperinflated alveoli due to uneven ventilation from surfactant deficiency. ### Pathophysiology **High-Yield:** Surfactant (a lipoprotein complex rich in phospholipids, especially dipalmitoylphosphatidylcholine [DPPC]) reduces surface tension in alveoli. Without it, alveoli collapse at end-expiration (atelectasis), requiring enormous pressure to re-expand them with each breath — leading to work of breathing, fatigue, and hypoxemia. ### Risk Factors for RDS | Factor | Impact | |--------|--------| | Prematurity (< 34 weeks) | Highest risk; surfactant immature | | Male sex | 1.5–2× higher risk than females | | Maternal diabetes | Delays fetal lung maturity | | Cesarean delivery (especially elective, without labor) | No thoracic compression to expel fetal lung fluid | | Perinatal asphyxia | Reduces surfactant synthesis | | Maternal hemorrhage / placental insufficiency | Fetal stress impairs maturation | ### Management Principles ```mermaid flowchart TD A[Preterm infant with RDS]:::outcome --> B{Antenatal corticosteroids given?}:::decision B -->|Yes, < 7 days before delivery| C[Reduced RDS severity & mortality]:::action B -->|No or > 7 days| D[Higher risk of severe disease]:::urgent A --> E[Postnatal management]:::action E --> F[Exogenous surfactant replacement]:::action E --> G[Respiratory support: CPAP or intubation]:::action E --> H[Oxygen titration to target SpO2]:::action F --> I[Improves lung compliance & oxygenation]:::outcome ``` **Clinical Pearl:** Antenatal corticosteroids (betamethasone or dexamethasone) given to the mother 24 hours to 7 days before preterm delivery significantly reduce RDS incidence and severity by accelerating fetal lung maturation. **Mnemonic: SURFACTANT** — **S**urface tension reduction, **U**neven ventilation (atelectasis), **R**eticular granular pattern (CXR), **F**etal immaturity, **A**ir bronchograms, **C**lassic in preterm, **T**iming early (first hours), **A**ntepartum steroids prevent, **N**eed exogenous replacement, **T**achypnea & grunting. **High-Yield:** Exogenous surfactant (e.g., beractant, poractant alfa) given via endotracheal tube within the first hours of life is the definitive treatment and dramatically improves survival and reduces chronic lung disease.